Change search
ReferencesLink to record
Permanent link

Direct link
A score to predict short-term risk of COPD exacerbations (SCOPEX)
Show others and affiliations
2015 (English)In: The International Journal of Chronic Obstructive Pulmonary Disease, ISSN 1176-9106, E-ISSN 1178-2005, Vol. 10, 201-209 p.Article in journal (Refereed) Published
Abstract [en]

Background: There is no clinically useful score to predict chronic obstructive pulmonary disease (COPD) exacerbations. We aimed to derive this by analyzing data from three existing COPD clinical trials of budesonide/formoterol, formoterol, or placebo in patients with moderate-tovery- severe COPD and a history of exacerbations in the previous year.

Methods: Predictive variables were selected using Cox regression for time to first severe COPD exacerbation. We determined absolute risk estimates for an exacerbation by identifying variables in a binomial model, adjusting for observation time, study, and treatment. The model was further reduced to clinically useful variables and the final regression coefficients scaled to obtain risk scores of 0-100 to predict an exacerbation within 6 months. Receiver operating characteristic (ROC) curves and the corresponding C-index were used to investigate the discriminatory properties of predictive variables.

Results: The best predictors of an exacerbation in the next 6 months were more COPD maintenance medications prior to the trial, higher mean daily reliever use, more exacerbations during the previous year, lower forced expiratory volume in 1 second/forced vital capacity ratio, and female sex. Using these risk variables, we developed a score to predict short-term (6-month) risk of COPD exacerbations (SCOPEX). Budesonide/formoterol reduced future exacerbation risk more than formoterol or as-needed short-acting beta(2)-agonist (salbutamol).

Conclusion: SCOPEX incorporates easily identifiable patient characteristics and can be readily applied in clinical practice to target therapy to reduce COPD exacerbations in patients at the highest risk.

Place, publisher, year, edition, pages
2015. Vol. 10, 201-209 p.
Keyword [en]
chronic obstructive pulmonary disease, exacerbation, model, predictor, inhaled corticosteroids, bronchodilators
National Category
Respiratory Medicine and Allergy
URN: urn:nbn:se:uu:diva-246668DOI: 10.2147/COPD.S69589ISI: 000348440500001PubMedID: 25670896OAI: diva2:796111
Available from: 2015-03-18 Created: 2015-03-09 Last updated: 2015-03-18Bibliographically approved

Open Access in DiVA

fulltext(636 kB)50 downloads
File information
File name FULLTEXT01.pdfFile size 636 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed
By organisation
Department of Medical SciencesUCR-Uppsala Clinical Research Center
In the same journal
The International Journal of Chronic Obstructive Pulmonary Disease
Respiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar
Total: 50 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 237 hits
ReferencesLink to record
Permanent link

Direct link